Biomerieux SA
F:EYWN

Watchlist Manager
Biomerieux SA Logo
Biomerieux SA
F:EYWN
Watchlist
Price: 73.45 EUR -0.94% Market Closed
Market Cap: €8.7B

Wall St Price Targets

EYWN Price Targets Summary
Biomerieux SA

Wall Street analysts forecast EYWN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EYWN is 131.56 EUR with a low forecast of 107.47 EUR and a high forecast of 169.28 EUR.

Lowest Forecast
Price Target
107.47 EUR
46% Upside
Average Forecast
Price Target
131.56 EUR
79% Upside
Highest Forecast
Price Target
169.28 EUR
130% Upside
Biomerieux SA Competitors:
Price Targets

Revenue
Forecast

8% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
8% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 5 years is 5%.

Gross Profit
Forecast

8% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
8% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 5 years is 5%.

Operating Income
Forecast

7% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
7% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 5 years is 8%.

Pre-Tax Income
Forecast

7% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
7% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 7%. The projected CAGR for the next 3 years is 15%.

Net Income
Forecast

9% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
9% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 9%. The projected CAGR for the next 5 years is 14%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is EYWN's stock price target?
Price Target
131.56 EUR

According to Wall Street analysts, the average 1-year price target for EYWN is 131.56 EUR with a low forecast of 107.47 EUR and a high forecast of 169.28 EUR.

What is the Revenue forecast for Biomerieux SA?
Projected CAGR
5%

Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 5 years is 5%.

What is the Gross Profit forecast for Biomerieux SA?
Projected CAGR
5%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 5 years is 5%.

What is the Operating Income forecast for Biomerieux SA?
Projected CAGR
8%

Over the last 13 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 5 years is 8%.

What is the Pre-Tax Income forecast for Biomerieux SA?
Projected CAGR
15%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 7%. The projected CAGR for the next 3 years is 15%.

What is the Net Income forecast for Biomerieux SA?
Projected CAGR
14%

Over the last 13 years, the compound annual growth rate for Net Income has been 9%. The projected CAGR for the next 5 years is 14%.

Back to Top